{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:52:56Z","timestamp":1785297176652,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["5 NU62PS924776-03"],"award-info":[{"award-number":["5 NU62PS924776-03"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["5 NU62PS924762-03"],"award-info":[{"award-number":["5 NU62PS924762-03"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01384-9","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:38:01Z","timestamp":1773333481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fentanyl use among people who inject drugs in two large Pacific Northwest metropolitan areas"],"prefix":"10.1186","volume":"23","author":[{"given":"Lauren","family":"Lipira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara N.","family":"Glick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalaine","family":"Sevillano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Town","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Menza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"1384_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138.","journal-title":"Int J Drug Policy"},{"issue":"8","key":"1384_CR2","volume":"13","author":"J Pergolizzi","year":"2021","unstructured":"Pergolizzi J, Magnusson P, LeQuang JAK, Breve F. Illicitly manufactured fentanyl entering the United States. Cureus. 2021;13(8):e17496.","journal-title":"Cureus"},{"key":"1384_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109398","volume":"234","author":"JJ Palamar","year":"2022","unstructured":"Palamar JJ, Ciccarone D, Rutherford C, Keyes KM, Carr TH, Cottler LB. Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021. Drug Alcohol Depend. 2022;234:109398.","journal-title":"Drug Alcohol Depend"},{"key":"1384_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","volume":"171","author":"J Suzuki","year":"2017","unstructured":"Suzuki J, El-Haddad S. A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017;171:107\u201316.","journal-title":"Drug Alcohol Depend"},{"issue":"17","key":"1384_CR5","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1001\/jama.2018.2844","volume":"319","author":"CM Jones","year":"2018","unstructured":"Jones CM, Einstein EB, Compton WM. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010\u20132016. JAMA. 2018;319(17):1819\u201321.","journal-title":"JAMA"},{"issue":"50","key":"1384_CR6","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","volume":"70","author":"J O'Donnell","year":"2021","unstructured":"O\u2019Donnell J, Tanz LJ, Gladden RM, Davis NL, Bitting J. Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls\u2014United States, 2019\u20132020. MMWR Morb Mortal Wkly Rep. 2021;70(50):1740\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"1384_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2105\/AJPH.2008.136937","volume":"99","author":"D Kim","year":"2009","unstructured":"Kim D, Irwin KS, Khoshnood K. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health. 2009;99(3):402\u20137.","journal-title":"Am J Public Health"},{"key":"1384_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","volume":"46","author":"N Fairbairn","year":"2017","unstructured":"Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172\u20139.","journal-title":"Int J Drug Policy"},{"issue":"14","key":"1384_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","volume":"66","author":"NJ Somerville","year":"2017","unstructured":"Somerville NJ, O\u2019Donnell J, Gladden RM, Zibbell JE, Green TC, Younkin M, et al. Characteristics of fentanyl overdose\u2014Massachusetts, 2014\u20132016. MMWR Morb Mortal Wkly Rep. 2017;66(14):382\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1384_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.drugpo.2019.10.004","volume":"74","author":"BH Lambdin","year":"2019","unstructured":"Lambdin BH, Bluthenthal RN, Zibbell JE, Wenger L, Simpson K, Kral AH. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. Int J Drug Policy. 2019;74:299\u2013304.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1384_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13011-023-00515-4","volume":"18","author":"A Kamal","year":"2023","unstructured":"Kamal A, Ferguson M, Xavier JC, Liu L, Graham B, Lock K, et al. Smoking identified as preferred mode of opioid safe supply use; investigating correlates of smoking preference through a 2021 cross-sectional study in British Columbia. Subst Abuse Treat Prev Policy. 2023;18(1):27.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"1384_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111318","volume":"259","author":"WH Eger","year":"2024","unstructured":"Eger WH, Abramovitz D, Bazzi AR, B\u00f3rquez A, Vera CF, Harvey-Vera A, et al. Changes in injecting versus smoking heroin, fentanyl, and methamphetamine among people who inject drugs in San Diego, California, 2020-2023. Drug Alcohol Depend. 2024;259:111318.","journal-title":"Drug Alcohol Depend"},{"key":"1384_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111419","volume":"263","author":"G Karandinos","year":"2024","unstructured":"Karandinos G, Unick J, Ondocsin J, Holm N, Mars S, Montero F, et al. Decrease in injection and rise in smoking and snorting of heroin and synthetic opioids, 2000-2021. Drug Alcohol Depend. 2024;263:111419.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"1384_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0303403","volume":"19","author":"D Ciccarone","year":"2024","unstructured":"Ciccarone D, Holm N, Ondocsin J, Schlosser A, Fessel J, Cowan A, et al. Innovation and adaptation: the rise of a fentanyl smoking culture in San Francisco. PLoS ONE. 2024;19(5):e0303403.","journal-title":"PLoS ONE"},{"key":"1384_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108314","volume":"216","author":"CL Shover","year":"2020","unstructured":"Shover CL, Falasinnu TO, Dwyer CL, Santos NB, Cunningham NJ, Freedman RB, et al. Steep increases in fentanyl-related mortality west of the Mississippi River: recent evidence from county and state surveillance. Drug Alcohol Depend. 2020;216:108314.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"1384_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.31612","volume":"7","author":"MJ Zoorob","year":"2024","unstructured":"Zoorob MJ, Park JN, Kral AH, Lambdin BH, Del Pozo B. Drug decriminalization, fentanyl, and fatal overdoses in Oregon. JAMA Netw Open. 2024;7(9):e2431612.","journal-title":"JAMA Netw Open"},{"key":"1384_CR17","doi-asserted-by":"publisher","first-page":"1347678","DOI":"10.3389\/fpsyt.2024.1347678","volume":"15","author":"VWL Tsang","year":"2024","unstructured":"Tsang VWL, Wong JSH, Westenberg JN, Ramadhan NH, Fadakar H, Nikoo M, et al. Systematic review on intentional non-medical fentanyl use among people who use drugs. Front Psychiatry. 2024;15:1347678.","journal-title":"Front Psychiatry"},{"issue":"Suppl 1","key":"1384_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/00333549071220S106","volume":"122","author":"KM Gallagher","year":"2007","unstructured":"Gallagher KM, Sullivan PS, Lansky A, Onorato IM. Behavioral surveillance among people at risk for HIV infection in the U.S.: the national HIV behavioral surveillance system. Public Health Rep. 2007;122(Suppl 1):32\u20138.","journal-title":"Public Health Rep"},{"issue":"2","key":"1384_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","volume":"44","author":"DD Heckathorn","year":"1997","unstructured":"Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174\u201399.","journal-title":"Soc Probl"},{"issue":"11","key":"1384_CR20","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1080\/10826084.2020.1762653","volume":"55","author":"A Mazhnaya","year":"2020","unstructured":"Mazhnaya A, O\u2019Rourke A, White RH, Park JN, Kilkenny ME, Sherman SG, et al. Fentanyl preference among people who inject drugs in West Virginia. Subst Use Misuse. 2020;55(11):1774\u201380.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1384_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/08897077.2021.1946892","volume":"43","author":"S Ickowicz","year":"2022","unstructured":"Ickowicz S, Kerr T, Grant C, Milloy MJ, Wood E, Hayashi K. Increasing preference for fentanyl among a cohort of people who use opioids in Vancouver, Canada, 2017\u20132018. Subst Abuse. 2022;43(1):458\u201364.","journal-title":"Subst Abuse"},{"issue":"2","key":"1384_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1037\/adb0000834","volume":"37","author":"AA Jones","year":"2023","unstructured":"Jones AA, Schneider KE, Mahlobo CT, Maggs JL, Dayton L, Tobin KE, et al. Fentanyl overdose concerns among people who inject drugs: the role of sex, racial minority status, and overdose prevention efforts. Psychol Addict Behav. 2023;37(2):191\u20138.","journal-title":"Psychol Addict Behav"},{"key":"1384_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.110955","volume":"251","author":"M Cano","year":"2023","unstructured":"Cano M, Mendoza N, Ignacio M, Rahman A, Daniulaityte R. Overdose deaths involving synthetic opioids: racial\/ethnic and educational disparities in the eastern and western US. Drug Alcohol Depend. 2023;251:110955.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1384_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12954-021-00539-8","volume":"18","author":"K Milaney","year":"2021","unstructured":"Milaney K, Passi J, Zaretsky L, Liu T, O\u2019Gorman CM, Hill L, et al. Drug use, homelessness and health: responding to the opioid overdose crisis with housing and harm reduction services. Harm Reduct J. 2021;18(1):92.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1384_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40352-021-00138-6","volume":"9","author":"E Kaplowitz","year":"2021","unstructured":"Kaplowitz E, Truong AQ, Macmadu A, Peterson M, Brinkley-Rubinstein L, Potter N, et al. Fentanyl-related overdose during incarceration: a comprehensive review. Health Justice. 2021;9(1):13.","journal-title":"Health Justice"},{"key":"1384_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12131268","author":"A Sahebi-Fakhrabad","year":"2024","unstructured":"Sahebi-Fakhrabad A, Sadeghi AH, Kemahlioglu-Ziya E, Handfield R. Exploring opioid prescription patterns and overdose rates in South Carolina (2017-2021): insights into rising deaths in high-risk areas. Healthcare. 2024. https:\/\/doi.org\/10.3390\/healthcare12131268.","journal-title":"Healthcare"},{"issue":"7","key":"1384_CR27","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1080\/10826084.2021.1901931","volume":"56","author":"DK Chandra","year":"2021","unstructured":"Chandra DK, Altice FL, Copenhaver MM, Zhou X, Didomizio E, Shrestha R. Purposeful fentanyl use and associated factors among opioid-dependent people who inject drugs. Subst Use Misuse. 2021;56(7):979\u201387.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1384_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10461-021-03381-y","volume":"26","author":"JN Park","year":"2022","unstructured":"Park JN, Owczarzak J, Urquhart G, Morris M, Weicker NP, Rouhani S, et al. HIV risk among urban and suburban people who inject drugs: elevated risk among fentanyl and cocaine injectors in Maryland. AIDS Behav. 2022;26(1):277\u201383.","journal-title":"AIDS Behav"},{"key":"1384_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpubeco.2022.104733","volume":"215","author":"A Packham","year":"2022","unstructured":"Packham A. Syringe exchange programs and harm reduction: new evidence in the wake of the opioid epidemic. J Public Econ. 2022;215:104733.","journal-title":"J Public Econ"},{"key":"1384_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.06.017","volume":"204","author":"J Gryczynski","year":"2019","unstructured":"Gryczynski J, Nichols H, Schwartz RP, Mitchell SG, Hill P, Wireman K. Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder. Drug Alcohol Depend. 2019;204:107515.","journal-title":"Drug Alcohol Depend"},{"key":"1384_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109003","volume":"227","author":"AH Kral","year":"2021","unstructured":"Kral AH, Lambdin BH, Browne EN, Wenger LD, Bluthenthal RN, Zibbell JE, et al. Transition from injecting opioids to smoking fentanyl in San Francisco, California. Drug Alcohol Depend. 2021;227:109003.","journal-title":"Drug Alcohol Depend"},{"key":"1384_CR32","unstructured":"StataCorp. (2019) Stata statistical software: release 16. College Station, TX: StataCorp LLC"},{"issue":"1","key":"1384_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00659-9","volume":"19","author":"SS Shin","year":"2022","unstructured":"Shin SS, LaForge K, Stack E, Pope J, Leichtling G, Larsen JE, et al. It wasn\u2019t here, and now it is. It\u2019s everywhere\": fentanyl\u2019s rising presence in Oregon\u2019s drug supply. Harm Reduct J. 2022;19(1):76.","journal-title":"Harm Reduct J"},{"issue":"5","key":"1384_CR34","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/jalm\/jfac041","volume":"7","author":"AA Reinhart","year":"2022","unstructured":"Reinhart AA, Simpson C, Yarid N, Haruff R, Baird GS. Investigation of fentanyl usage in the Seattle area. J Appl Lab Med. 2022;7(5):1164\u20138.","journal-title":"J Appl Lab Med"},{"issue":"2","key":"1384_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.15585\/mmwr.mm6802a3","volume":"68","author":"C Colon-Berezin","year":"2019","unstructured":"Colon-Berezin C, Nolan ML, Blachman-Forshay J, Paone D. Overdose deaths involving fentanyl and fentanyl Analogs\u2014New York City, 2000\u20132017. MMWR Morb Mortal Wkly Rep. 2019;68(2):37\u201340.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1384_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.annepidem.2023.01.009","volume":"79","author":"H Lu","year":"2023","unstructured":"Lu H, Crawford FW, Gonsalves GS, Grau LE. Geographic and temporal trends in fentanyl-detected deaths in Connecticut, 2009\u20132019. Ann Epidemiol. 2023;79:32\u20138.","journal-title":"Ann Epidemiol"},{"key":"1384_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","volume":"106","author":"SD Comer","year":"2019","unstructured":"Comer SD, Cahill CM. Fentanyl: receptor pharmacology, abuse potential, and implications for treatment. Neurosci Biobehav Rev. 2019;106:49\u201357.","journal-title":"Neurosci Biobehav Rev"},{"key":"1384_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109630","volume":"240","author":"KR Hochstatter","year":"2022","unstructured":"Hochstatter KR, Terplan M, Mitchell SG, Schwartz RP, Dusek K, Wireman K, et al. Characteristics and correlates of fentanyl preferences among people with opioid use disorder. Drug Alcohol Depend. 2022;240:109630.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1384_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02791072.2023.2176954","volume":"56","author":"FR Lamy","year":"2024","unstructured":"Lamy FR, Daniulaityte R, Dudley S Jr. Pressed OXY M30 Pills, Great Press, Potent, Fast Shipping!!!\": availability of counterfeit and pharmaceutical oxycodone pills on one major cryptomarket. J Psychoactive Drugs. 2024;56(1):1\u20137.","journal-title":"J Psychoactive Drugs"},{"key":"1384_CR40","unstructured":"UW Medicine Newsroom. 2021. [cited 2024]. Available from: https:\/\/newsroom.uw.edu\/blog\/qa-fentanyls-growth-among-overdoses-stunning."},{"issue":"6","key":"1384_CR41","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s10461-022-03908-x","volume":"27","author":"KS Kenny","year":"2023","unstructured":"Kenny KS, Kolla G, Greig S, Bannerman M, Phillips D, Altenberg J, et al. Association of illicit fentanyl use with injection risk practices among people who inject drugs. AIDS Behav. 2023;27(6):1757\u201365.","journal-title":"AIDS Behav"},{"key":"1384_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103467","volume":"99","author":"SE Duhart Clarke","year":"2022","unstructured":"Duhart Clarke SE, Kral AH, Zibbell JE. Consuming illicit opioids during a drug overdose epidemic: illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market. Int J Drug Policy. 2022;99:103467.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1384_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12954-021-00479-3","volume":"18","author":"G Bardwell","year":"2021","unstructured":"Bardwell G, Austin T, Maher L, Boyd J. Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs. Harm Reduct J. 2021;18(1):29.","journal-title":"Harm Reduct J"},{"issue":"6","key":"1384_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.15585\/mmwr.mm7306a2","volume":"73","author":"LJ Tanz","year":"2024","unstructured":"Tanz LJ, Gladden RM, Dinwiddie AT, Miller KD, Broz D, Spector E, et al. Routes of drug use among drug overdose deaths\u2014United States, 2020\u20132022. MMWR Morb Mortal Wkly Rep. 2024;73(6):124\u201330.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"1384_CR45","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1080\/08897077.2022.2074597","volume":"43","author":"AV Rivera","year":"2022","unstructured":"Rivera AV, Nolan ML, Paone D, Carrillo SA, Braunstein SL. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018. Subst Abuse. 2022;43(1):1172\u20139.","journal-title":"Subst Abuse"},{"key":"1384_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109478","volume":"236","author":"PO Coffin","year":"2022","unstructured":"Coffin PO, Maya S, Kahn JG. Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin. Drug Alcohol Depend. 2022;236:109478.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1384_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5811\/westjem.2020.10.48768","volume":"22","author":"JT Lai","year":"2021","unstructured":"Lai JT, Goldfine CE, Chapman BP, Taylor MM, Rosen RK, Carreiro SP, et al. Nobody wants to be narcan\u2019d: a pilot qualitative analysis of drug users\u2019 perspectives on naloxone. West J Emerg Med. 2021;22(2):339\u201345.","journal-title":"West J Emerg Med"},{"key":"1384_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drugalcdep.2018.09.006","volume":"193","author":"S Mayer","year":"2018","unstructured":"Mayer S, Boyd J, Collins A, Kennedy MC, Fairbairn N, McNeil R. Characterizing fentanyl-related overdoses and implications for overdose response: findings from a rapid ethnographic study in Vancouver, Canada. Drug Alcohol Depend. 2018;193:69\u201374.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1384_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12954-022-00664-y","volume":"19","author":"MC Frost","year":"2022","unstructured":"Frost MC, Austin EJ, Corcorran MA, Briggs ES, Behrends CN, Juarez AM, et al. Responding to a surge in overdose deaths: perspectives from US syringe services programs. Harm Reduct J. 2022;19(1):79.","journal-title":"Harm Reduct J"},{"key":"1384_CR50","unstructured":"Kingston S, Newman A, Banta-Green C, Glick S. Results from the 2021 WA State Syringe Service Program Health Survey. Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, University of Washington: Seattle, WA. 2022."},{"issue":"1","key":"1384_CR51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1467-9531.2010.01223.x","volume":"40","author":"KJ Gile","year":"2010","unstructured":"Gile KJ, Handcock MS. Respondent-driven sampling: an assessment of current methodology. Sociol Methodol. 2010;40(1):285\u2013327.","journal-title":"Sociol Methodol"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01384-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:15:56Z","timestamp":1779682556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01384-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1384"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01384-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6597345\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided verbal, documented, informed consent for study activities. Portland and Seattle NHBS data collection and data sharing procedures were reviewed and approved by the Oregon Health Authority Science and Epidemiology Council\u2019s Project Review Team and the Washington State IRB (WSIRB), respectively.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SG reports a relationship with Cepheid that includes funding grants. LS reports financial support was provided by Centers for Disease Control and Prevention. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}